![John Sundy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Sundy
Directeur/Bestuurslid bij
SANOFI
Profiel
Dr. John Sundy is an Independent Director at Sanofi and a Chief Medical Officer at Seismic Therapeutic, Inc. He is on the Board of Directors at Sanofi, Childhood Arthritis & Rheumatology Research Alliance and Neutrolis, Inc. Dr. Sundy was previously employed as a Chief Medical Officer by Pandion Therapeutics, Inc., a Senior Vice President by Gilead Sciences, Inc., an Associate Professor by Duke University, and an Associate Professor by Duke-NUS Graduate Medical School Singapore.
He received his undergraduate degree from Bucknell University, a doctorate degree from Hahnemann University and a doctorate degree from Drexel University College of Medicine.
Actieve functies van John Sundy
| Bedrijven | Functie | Begin |
|---|---|---|
| SANOFI | Directeur/Bestuurslid | 30-04-2024 |
Seismic Therapeutic, Inc.
 Seismic Therapeutic, Inc. Packaged SoftwareTechnology Services Develops machine learning immunology therapies | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
Neutrolis, Inc.
 Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for autoimmune and inflammatory diseases | Directeur/Bestuurslid | 01-01-2022 |
Childhood Arthritis & Rheumatology Research Alliance | Directeur/Bestuurslid | - |
Eerdere bekende functies van John Sundy
| Bedrijven | Functie | Einde |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-04-2020 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2014 |
Duke-NUS Graduate Medical School Singapore
 Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2014 |
Opleiding van John Sundy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
94
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke-NUS Graduate Medical School Singapore
Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
Neutrolis, Inc.
Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for autoimmune and inflammatory diseases | Health Technology |
Seismic Therapeutic, Inc.
Seismic Therapeutic, Inc. Packaged SoftwareTechnology Services Develops machine learning immunology therapies | Technology Services |
Childhood Arthritis & Rheumatology Research Alliance |
